From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|2|1|24-28

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.2, Iss.1, 2008-01, pp. : 24-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulatory Effects of Peroxisome Proliferator-Activated Receptor-&ggr; on CXCR3 Chemokines

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 8, Iss. 2, 2014-05 ,pp. : 132-138

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators. Current and Future Treatment Options for Osteoporosis

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 206-218

Bentham Science Publishers

Access to resources Recommend Favorite

Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 142-151

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 177-187

Bentham Science Publishers

Access to resources Recommend Favorite

Adsorption of Benzene Vapor onto Activated Biomass from Cashew Nut Shell: Batch and Column Study

By Suresh S.   Vijayalakshmi G.   Rajmohan B.   Subbaramaiah V.  

Recent Patents on Chemical Engineering, Vol. 5, Iss. 2, 2012-08 ,pp. : 116-133

Bentham Science Publishers

Access to resources Recommend Favorite